Department of Health and Social Care

The number of prescription items prescribed in England to women between the ages of 18 to 52 years old for sodium valproate in 2024 was 201,834.

Valproate must not be prescribed to women under the age of 55 years old who are able to have children, unless two specialists independently consider and document that there is no other effective or tolerated treatment, and the patient fulfils the conditions of a Pregnancy Prevention Programme (PPP). As part of the PPP, healthcare professionals should discuss the risks of valproate in pregnancy with the patient and the need to take effective contraception. The number of women who become pregnant while on valproate is very small and is monitored. Pregnant women with epilepsy should only be treated with valproate if there are no other treatment options.

The Medicines and Healthcare products Regulatory Agency has recently updated its guidance to assist healthcare professionals, including midwives, in supporting all women, especially those who are pregnant or planning a pregnancy. This updated guidance is readily available online.

The Government is currently reviewing options for the implementation of the Liberty Protection Safeguards. Introduction of the Liberty Protection Safeguards would include a revised Code of Practice. We will set out our plans in due course.

The Government and NHS England remain committed to recovering the dementia diagnosis rate. The new approach to planning guidance will improve the operating model, giving local leaders the freedom and autonomy they need to provide the best services to their local community, including those with dementia.

The NHS Health Check, a core component of England’s cardiovascular disease (CVD) prevention programme, aims to prevent some cases of dementia in eligible people by making them aware that many of the risk factors for CVD are the same as those for dementia, and that what is good for the heart is also good for the brain. Through the programme, people aged 65 to 74 years old are also made aware of the signs and symptoms of dementia, and are signposted to local memory services where appropriate.

We are considering the guidance supporting the dementia component of the NHS Health Check, to ensure it reflects the most recent evidence and best practice.

Integrated care boards are responsible for determining and meeting the mental health needs of the young people in their local populations, and there are no plans to publish statutory guidance in this area. The Department expects integrated care boards to continue to improve access to community-based mental health support for children and young people under our plans to shift more care out of hospitals and into the community, under the 10-Year Health Plan.

The following table shows the latest East Midlands Ambulance Service response times by ambulance incident category:

Source: NHS England Ambulance Quality Indicators 2025/26

Notes:

1. the latest data available is for May 2025; and
2. the data format is hours: minutes: seconds.

Government responsibility for delivering dementia research is shared between the Department of Health and Social Care, with research delivered via the National Institute for Health and Care Research (NIHR), and the Department for Science, Innovation and Technology, with research delivered via UK Research and Innovation.

The Government’s Dame Barbara Windsor Dementia Goals programme has invested £13 million into a range of biomarker innovation projects which include a broad range of biomarker technologies, ranging from an artificial intelligence tool designed to improve the accuracy of blood tests for dementia, to using retinal scans to detect early-onset dementia decades before symptoms. Some of these innovations could support improved diagnosis in the future, if validated for clinical use.

Alongside Alzheimer’s Research UK, Alzheimer’s Society, and the People’s Postcode Lottery, the NIHR is funding the Blood Biomarker Challenge which seeks to produce the clinical and economic data that could make the case for the use of a blood test in the National Health Service to support diagnosis of dementia.

The NIHR has also invested nearly £11 million of funding to develop new digital approaches for the timely detection and diagnosis of dementia. Funded projects include a range of innovative tests such as spatial awareness, image recognition, hearing tests, and monitoring sleep disturbances.

The UK Dementia Research Institute, primarily funded by the Government, aims to increase our basic scientific understanding of dementia and its causes, unlocking pathways to developing ways to prevent, diagnose, and treat the condition. The NIHR is investing £20 million in the UK Dementia Research Institute over four years to enable discoveries to be taken out of the laboratory and into the lives of people that need them.

The NIHR continues to welcome funding applications for research into any aspect of human health and care, including dementia. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.

Welcoming applications on dementia to all NIHR programmes enables maximum flexibility both in terms of the amount of research funding a particular area can be awarded, and the type of research which can be funded.

As set out in the 10-Year Health Plan published on 3 July, we will work across Government to prioritise United Kingdom medical graduates for foundation training, and to prioritise UK medical graduates and other doctors who have worked in the National Health Service for a significant period for specialty training.

We will publish a new 10 Year Workforce Plan later this year to deliver the transformed health service we will build over the next decade, and treat patients on time again.

We expect integrated care boards to commission fertility services in line with National Institute for Health and Care Excellence (NICE) guidelines. NICE is currently reviewing the fertility guidelines and will consider whether the current recommendations for access to National Health Service-funded treatment are still appropriate.

In the light of broader pressures on the National Health Service and on-going changes within NHS England, we have been looking again at achievable ambitions to improve access to fertility services and fairness for all affected couples.

The Privy Council must be satisfied that it has all the required information before it can make a final decision to award Dental Authority Status to an organisation.

I understand that the Privy Council Office has recently requested additional information from Portsmouth Dental Academy pertinent to its application, and that it is awaiting a response.

It is the responsibility of the integrated care boards (ICBs) in England to make appropriate provision to meet the health and care needs of their local population, including providing access to attention deficit hyperactivity disorder (ADHD) assessment and treatment, in line with relevant National Institute for Health and Care Excellence guidelines.

The independent ADHD taskforce, commissioned by NHS England, is bringing together those with lived experience with experts from the National Health Service, education, charity, and justice sectors to get a better understanding of the challenges affecting those with ADHD, including in accessing services and support. An interim report was published on 20 June. The ADHD taskforce's final report is expected to be published later this year, and we will carefully consider its recommendations.

As of 31 May 2025, 58 general practitioners (GPs) have been recruited through the Additional Roles Reimbursement Scheme in the North East and North Cumbria Integrated Care Board (ICB) since 1 October 2024, the ICB in which the North Northumberland constituency is located. Data is not available at a constituency level.

Earlier in the year we announced that we are investing an additional £889 million through the GP Contract for 2025/26 to reinforce the front door of the National Health Service, bringing total spend on the GP Contract to £13.2 billion. This is the biggest increase in over a decade.

Every year we consult with the British Medical Association’s General Practice Committee both about what services practices provide, and the money they are entitled to in return under their contract, taking account the costs of delivering services. Practices are required to provide services to meet the reasonable needs of the patients registered at their practice. This includes making their own workforce plans.

The Department has made no assessment of the cost to the public purse of the requirement for patients to renew their medical exemption certificate every five years.

Digital clinics do not currently fall within the Human Fertilisation and Embryology Act and therefore are out outside of the Human Fertilisation and Embryology Authority’s (HFEA) remit at present.

The HFEA published Modernising Fertility Law in November 2023, which made a number of recommendations for legislative change, including around its regulatory powers.

Ministers have met with the HFEA Chair and discussed the emerging regulatory challenges. The Government is considering the HFEA’s priorities for changing the law and will decide how to take this forward at the earliest opportunity.

There are no plans to amend these regulations to require colleges and universities to hold emergency inhalers. These are not controlled environments like schools, which require parents to inform them if their children need an inhaler. Colleges and universities typically have much larger enrolment numbers than schools, with their students having greater freedom of movement than schools. Colleges and universities also have students of adult age who are responsible, as adults, for ensuring both have and properly use their inhalers.

Emergency inhalers in schools are a back-up and not a substitution for a child having their own inhaler to hand. The emergency inhaler is for use in the event a child’s inhaler is empty, broken or unavailable.

By virtue of the wording of the School Standards and Framework Act 1998, the Human Medicines (Amendment) (No. 2) Regulations 2014 also apply to maintained nursery schools, namely state-funded early years settings, controlled and funded by the local authority.

Evidence has not been presented that suggests it is necessary to extend the regulations to all non-state-run nurseries in England. Parents of children with asthma attending nursery should ensure that their child, or the nursery, has the child’s inhaler available.

Supporting women’s health before, during, and after pregnancy is a priority for the Government. The women’s health area on the National Health Service’s website brings together over 100 health topics for women seeking health information, including information and advice on planning for pregnancy, keeping well in pregnancy, and pelvic health.

NHS England has rolled out perinatal pelvic health services to support the prevention and identification of pelvic floor dysfunction, including incontinence, during pregnancy and post-birth. Additionally, NHS England the Royal College of General Practitioners have published guidance on the six to eight week postnatal check-up. This check-up provides personalised postnatal care for women’s physical and mental health, including a specific section on pelvic floor health.

The Change NHS portal was available in English, Urdu, Romanian, Punjabi, and Polish, as these are the five most common languages in England, as reported by the 2021 Census. Participants at 10-Year Health Plan deliberative engagement events were given the option to request translation into any other language.

My Rt Hon. Friend, the Secretary of State for Health and Social Care accepted the headline pay recommendations for National Health Service staff from the independent pay review bodies, and staff will receive their backdated pay uplifts from August

The Department conducted an equality impact assessment of the new pay framework for very senior managers (VSMs), which includes the provision to withhold pay uplifts for VSMs working in underperforming organisations, defined as the organisations placed in segment five of the new NHS Oversight Framework.

It found that, overall, the proposal to withhold pay uplifts for VSMs in segments five is not expected to result in a statistically significant difference in relation to protected characteristics. As VSMs are not employed on national contracts, local remuneration committees will be required to assess the impact on equalities in relation to decisions on pay at an organisation level.

The Government recognises that urgent and emergency care performance has fallen short in recent years and is committed to restoring accident and emergency waiting times to the NHS Constitutional standard across England, including in Eastbourne.

Our Urgent and Emergency Care Plan for 2025/26 sets out a fundamental shift in the approach to urgent and emergency care. It will drive collaboration across the system to deliver improvements for patients this year, and is backed by nearly £450 million of capital investment.

Furthermore, our 10-Year Health Plan sets out how we will reduce waiting times in accident and emergency by shifting care into the community through new neighbourhood health services, forming a key part of our mission to reform the National Health Service.

The proposals for the clustering of integrated care boards (ICBs) across England were considered in view of the ambition set out in the Government’s 10-Year Health Plan and NHS England’s Model ICB Blueprint. Specifically, the Government’s aim to strengthen the role of ICBs as strategic commissioners whilst delivering efficiency savings through creating leaner and more agile structures.

Although the Government will not publish a detailed analysis of the options considered in each region, options for the re-organisation of ICBs in the east of England were considered in view of the ambition detailed above, with careful consideration of the local circumstances and meeting the running cost allowance envelope of £18.76 per head of population.

Decisions on the employment of newly qualified nurses are a matter for individual National Health Service trusts, which manage their recruitment at a local level, ensuring they have the right number of staff in place, with the right skill mix, to deliver safe and effective care.

We are working closely with NHS England, employers, universities, and regional nursing leads to ensure support is in place to help graduating nurses find a role as soon as possible after qualification and transition into the workplace.

The clustering of integrated care boards (ICBs) in Bedfordshire, Luton, and Milton Keynes (BLMK), and Hertfordshire, Cambridgeshire and Peterborough is not expected to have a direct impact on primary care provision. ICBs will remain responsible for ensuring adequate primary care provision for the communities they serve. There are exploratory discussions underway between the BLMK ICB, the Central Bedfordshire Council, the developer of Wixams Town Centre, and Bedford Borough Council regarding options for delivering permanent healthcare provision in Wixams. These discussions are ongoing.

As the plans for ICB reconfiguration progress, there remains a focus on place-based working and maintaining strong relationships with local partners.

The Department has no plans to reinstate the bursary for podiatry students, however the Government keeps funding arrangements for all healthcare students under close review.

Supplementary financial support is available to podiatry students through the NHS Learning Support Fund (LSF). The LSF offers non-repayable funding, in addition to maintenance and tuition fee loans provided by the Student Loans Company. This includes a non-repayable training grant of £5,000 per academic year plus an additional specialist subject payment of £1,000 a year for podiatry students, and where eligible, £2,000 per year for students with childcare responsibilities.

We will publish a 10 Year Workforce Plan to ensure the National Health Service has the right people, in the right places, with the right skills to care for patients when they need it.

The Nursing and Midwifery Council (NMC) publishes information on the number of United Kingdom trained nurses joining their register for the first time, who are resident in England. The following table shows the number of UK trained nurses joining the NMC register in England for the first time by financial year:

Source: Nursing and Midwifery Council, March 2025 Annual Data Report.

The Department does not hold information on the number of graduates who are employed within six months.

NHS England has asked the integrated care boards (ICBs) to act primarily as strategic commissioners of health and care services and to reduce the duplication of responsibilities within the health and care structure. ICBs are responsible for commissioning health and care services for every person within their locality, including people from small and rural communities. We expect ICBs to continue delivering on all of their statutory responsibilities for all of their residents, including those from small and rural communities.

The handling of patient complaints in the National Health Service is governed by the Local Authority Social Services and National Health Service Complaints (England) Regulations 2009. These regulations set out in law the minimum standards NHS organisations must adhere to in respect of their complaint handling arrangements.

There are strong protections in law to ensure that health and care information is used in a safe, secure, and legal way, and these must be observed in any complaints process. These include: the UK General Data Protection Regulation; the Data Protection Act 2018, which establishes a legal framework for processing personal information and keeping it secure, and for only using it for the purposes for which it was collected; the Human Rights Act 1998, which requires public bodies to respect the private life of an individual, including protecting any information held about them; and the common law duty of confidentiality.

No assessment has been made. The assessment and management of frequent callers is made at a local level by the relevant ambulance trust.

The devolution of health is a long-standing policy, and no assessment has been made.

For patients living in border communities, we expect local health care services to work closely to ensure differing targets and waiting lists are managed appropriately and effectively to meet the needs of the communities they serve.

We work closely with partners across the devolved administrations to provide support and share best practice to reduce waiting lists. This includes sharing learning as the National Health Service in England makes progress toward delivering the Government’s ambition of ensuring that 92% of patients will wait no longer than 18 weeks from referral to consultant-led treatment, in line with the NHS constitutional standard, by March 2029.

The Government has now exceeded its pledge to deliver two million extra operations, scans, and appointments in England, having delivered 4.2 million additional appointments.

NHS England considered abiraterone as an off-label treatment for hormone sensitive, non-metastatic prostate cancer through its clinical policy development process in 2024/25. Through this process, NHS England confirmed that there was sufficient supporting evidence to support the routine commissioning of abiraterone in this indication, and it was ranked in the highest priority level. However, at this point in time, it has not been possible to identify the necessary recurrent headroom in revenue budgets to support the funding of any treatments under consideration. This position is being kept under review.

NHS England examined papers from the STAMPEDE trial, including Cost utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data, as part of the review of evidence for the policy proposition.

The Government recognises that ambulance response times, including in Surrey and Hampshire, are not meeting the high standards patients should expect.

We are determined to turn things around, and our Urgent and Emergency Care Plan for 2025/26, backed by almost £450 million of capital investment, commits to reducing ambulance response times for Category 2 incidents to 30 minutes on average this year.

Our 10-Year Health Plan sets out how we will reform the National Health Service, including urgent and emergency care services, with a key focus on shifting urgent care into the community through new Neighbourhood Health Services.

The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based recommendations for the National Health Service on whether new medicines represent a clinically and cost-effective use of resources. The NHS in England is legally required to fund medicines recommended by NICE, normally within three months of the publication of final guidance.

NICE has selected tofersen for treating amyotrophic lateral sclerosis caused by SOD1 gene mutations as a topic for guidance development through its Highly Specialised Technology (HST) programme. The HST programme appraises medicines for the treatment of very rare, and often very severe diseases and evaluates whether they can be considered a clinically and cost-effective use of NHS resources. NICE is working with the company to confirm timelines for this evaluation.

The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based recommendations for the National Health Service on whether new medicines represent a clinically and cost-effective use of resources. The NHS in England is legally required to fund medicines recommended by NICE, normally within three months of the publication of final guidance.

NICE has selected tofersen for treating amyotrophic lateral sclerosis caused by SOD1 gene mutations as a topic for guidance development through its Highly Specialised Technology (HST) programme. The HST programme appraises medicines for the treatment of very rare, and often very severe diseases and evaluates whether they can be considered a clinically and cost-effective use of NHS resources. NICE is working with the company to confirm timelines for this evaluation.

In order to optimise the impact of strategic commissioning, and release resources to the frontline, we are working with integrated care boards to so that they cover populations of approximately two million people.

The Government is committed to taking action to address longstanding concerns about the safety of the cosmetics sector, and is exploring options for further regulation in this area. We will set out the details of our approach in our response to the consultation on the licensing of non-surgical cosmetic procedures in England, which we will publish as soon as possible.

Following the Prime Minister’s announcement of the abolition of NHS England, we are clear on the need for a smaller centre, as well as reducing integrated care board running costs and National Health Service provider corporate costs, in order to reduce waste and bureaucracy. Good progress is being made, with the Department and NHS England having announced voluntary exit or redundancy schemes.

We have recently announced the Spending Review settlement which provides an additional £29 billion of annual day to day spending in real terms by 2028/29, compared to 2023/24. Ahead of asking the NHS to commence a multi-year planning round, we are now carefully reviewing how the settlement is prioritised, including making provision for redundancy costs.

National Health Service contracts or agreements for the provision of services locally are made and held at a local level by the relevant NHS body. There are no current plans to change this approach.

No such discussions have taken place. Information on how to access NHS Talking Therapies services is available from general practitioners, National Health Service mental health providers, voluntary, community, and social enterprise organisations, and at the following link:

https://www.nhs.uk/mental-health/talking-therapies-medicine-treatments/talking-therapies-and-counselling/

No such discussions have taken place. Information on how to access NHS Talking Therapies services is available from general practitioners, National Health Service mental health providers, voluntary, community, and social enterprise organisations, and at the following link:

https://www.nhs.uk/mental-health/talking-therapies-medicine-treatments/talking-therapies-and-counselling/

NHS England has provided £26 million in revenue funding for children and young people’s hospices for 2025/26, through what was, until recently, known as the Children and Young People’s Hospice Grant. This was an increase in funding from £25 million in 2024/25.

Integrated care boards will once again administer the funding to their respective children and young people’s hospices on behalf of NHS England. The majority of children and young people’s hospices should now have received their allocations, with the remaining few receiving theirs in the coming weeks.

We cannot yet confirm what the funding for 2026/27 will be, or how it will be administered.

In February, I met with key palliative care and end of life care and hospice stakeholders, including Together for Short Lives, in a roundtable format with a focus on long-term sector sustainability within the context of our 10-Year Health Plan.

It is the responsibility of integrated care boards (ICBs) to make available appropriate provision to meet the health and care needs of their local population, including assessments and support for people suspected or confirmed as having attention deficit hyperactivity disorder (ADHD).

Lord Darzi’s independent review of the National Health Service, published September 2024, highlighted that the demand for assessments for ADHD has grown significantly in recent years and that there are severe delays for accessing ADHD assessments.

The independent ADHD taskforce, commissioned by NHS England to consider these issues and how to address them, recently published its interim report. The report recommends the need for timely access to needs-based support, including practical help for people showing signs of ADHD, such as coaching, classroom tools, and parenting advice. The taskforce's final report is expected to be published later this year, and we will carefully consider its recommendations.

The Government is also supporting earlier intervention for children with special educational needs and disabilities (SEND) through the Early Language Support for Every Child and the Partnerships for Inclusion of Neurodiversity in Schools programmes. The Government will be investing in support for pupils with SEND more widely, enabling transformation of the SEND system to make mainstream schools more inclusive and to improve outcomes.

The revised Accessible Information Standard (AIS) was published on 1 July, and is available at the following link:

https://www.england.nhs.uk/accessible-information-standard/

NHS England is working to support implementation of the AIS with awareness raising, communication and engagement, and a review of the current e-learning modules on the AIS. The intention is to ensure that staff and organisations in the National Health Service are aware of the AIS and the importance of meeting the information and communication needs of disabled people using services.

Since 2016, all NHS organisations and publicly funded social care providers are expected to meet the AIS, which details the recommended approach to supporting the information and communication support needs of patients and carers with a disability, impairment, or sensory loss.

The responsibility for monitoring compliance with the AIS sits with the commissioner of the service.

The revised standard requires those staff in relevant communication and information roles to be adequately trained. The AIS conformance criteria, published in 2016 and updated in June 2025, set out how organisations should comply with the AIS. NHS England is leading a system wide review of mandatory training which will include a new governance framework and a table of statutory obligations as well as a new competency framework setting out all nationally mandated subjects and learning outcomes.

Following the commencement of regulations made under the Health and Care Act 2022, mandatory information standards will be introduced in a staged process. NHS England will consider the case for developing a mandatory AIS standard, and the timing for this, along with the other existing standards.

The revised Accessible Information Standard (AIS) was published on 1 July, and is available at the following link:

https://www.england.nhs.uk/accessible-information-standard/

NHS England is working to support implementation of the AIS with awareness raising, communication and engagement, and a review of the current e-learning modules on the AIS. The intention is to ensure that staff and organisations in the National Health Service are aware of the AIS and the importance of meeting the information and communication needs of disabled people using services.

Since 2016, all NHS organisations and publicly funded social care providers are expected to meet the AIS, which details the recommended approach to supporting the information and communication support needs of patients and carers with a disability, impairment, or sensory loss.

The responsibility for monitoring compliance with the AIS sits with the commissioner of the service.

The revised standard requires those staff in relevant communication and information roles to be adequately trained. The AIS conformance criteria, published in 2016 and updated in June 2025, set out how organisations should comply with the AIS. NHS England is leading a system wide review of mandatory training which will include a new governance framework and a table of statutory obligations as well as a new competency framework setting out all nationally mandated subjects and learning outcomes.

Following the commencement of regulations made under the Health and Care Act 2022, mandatory information standards will be introduced in a staged process. NHS England will consider the case for developing a mandatory AIS standard, and the timing for this, along with the other existing standards.

The revised Accessible Information Standard (AIS) was published on 1 July, and is available at the following link:

https://www.england.nhs.uk/accessible-information-standard/

NHS England is working to support implementation of the AIS with awareness raising, communication and engagement, and a review of the current e-learning modules on the AIS. The intention is to ensure that staff and organisations in the National Health Service are aware of the AIS and the importance of meeting the information and communication needs of disabled people using services.

Since 2016, all NHS organisations and publicly funded social care providers are expected to meet the AIS, which details the recommended approach to supporting the information and communication support needs of patients and carers with a disability, impairment, or sensory loss.

The responsibility for monitoring compliance with the AIS sits with the commissioner of the service.

The revised standard requires those staff in relevant communication and information roles to be adequately trained. The AIS conformance criteria, published in 2016 and updated in June 2025, set out how organisations should comply with the AIS. NHS England is leading a system wide review of mandatory training which will include a new governance framework and a table of statutory obligations as well as a new competency framework setting out all nationally mandated subjects and learning outcomes.

Following the commencement of regulations made under the Health and Care Act 2022, mandatory information standards will be introduced in a staged process. NHS England will consider the case for developing a mandatory AIS standard, and the timing for this, along with the other existing standards.

The Government recognises the transformative potential of digital technology for people who draw on adult social care. While the Department is not developing a digital strategy for social care users at this time, we are taking forward immediate reforms to ensure that people who draw on care benefit from digital transformation. These reforms build on progress to drive adoption of digital social care records, which now benefit 85% of people who draw on adult social care, as well as Government-funded testing, scaling, and evaluation of care technologies to help people live independently for longer.

We are developing new standards and guidance for care technologies to improve the confidence of people who draw on care, their loved ones, and care providers, to purchase effective and compatible products.

We are also developing new national data infrastructure for social care, which will lay the foundations for staff to access real-time information from health and care services. This will enable the right people to access the right information at the right time, which is key to ensuring people receive safe, personalised care, without having to repeat themselves multiple times to different health and care professionals. We aim for all care providers to be fully digitised by the end of the Parliament.

To support the digitisation of adult social care, we have produced a digital skills learning offer. By developing the digital skills, confidence, and capabilities of the adult social care workforce, we can empower them to support the people drawing on care to choose the care technology that is right for them.

We are continuing our work with delivery partners to support local authorities in digitising adult social care assessments. This support is helping local authorities improve the timeliness and efficiency of assessments. Where digital tools have been trialled, evaluations have shown that people drawing on care and support have experienced quicker assessments, leading to reduced waiting times.

We are investing an additional £889 million in GPs for 2025/26, bringing total spending on the GP Contract to £13.2 billion. This is the largest uplift to GP funding since the beginning of the five-year framework, and means we are reversing recent trends by allocating a rising share of National Health Service resources to GPs.

Under recently announced changes to the GP Contract in 2025/26, the Additional Roles Reimbursement Scheme (ARRS) will become more flexible to allow primary care networks to respond better to local workforce needs. The two ARRS pots have been combined to create a single pot for the reimbursement of patient-facing staff costs. There will be no restrictions on the number or type of staff covered, including GPs and practice nurses.

In the Epsom and Ewell constituency, as of 31 May 2025, there were 67.8 full time equivalent doctors in GPs, and since October 2024, 1,900 GPs have been recruited via the ARRS nationally.